Cargando…

生物材料增效NK细胞免疫疗法研究进展

NK cell immunotherapy is a promising antitumor therapeutic modality after the development of T cell immunotherapy. Structural modification of NK cells with biomaterials may provide a precise, efficient, and low-cost strategy to enhance NK cell immunotherapy. The biomaterial modification of NK cells...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 《浙江大学学报》编辑部 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409897/
https://www.ncbi.nlm.nih.gov/pubmed/37476938
http://dx.doi.org/10.3724/zdxbyxb-2022-0728
_version_ 1785086343032864768
collection PubMed
description NK cell immunotherapy is a promising antitumor therapeutic modality after the development of T cell immunotherapy. Structural modification of NK cells with biomaterials may provide a precise, efficient, and low-cost strategy to enhance NK cell immunotherapy. The biomaterial modification of NK cells can be divided into two strategies: surface engineering with biomaterials and intracellular modification. The surface engineering strategies include hydrophobic interaction of lipids, receptor-ligand interaction between membrane proteins, covalent binding to amino acid residues, click reaction and electrostatic interaction. The intracellular modification strategies are based on manipulation by nanotechnology using membranous materials from various sources of NK cells (such as exosome, vesicle and cytomembranes). Finally, the biomaterials-based strategies regulate the recruitment, recognition and cytotoxicity of NK cells in the solid tumor site in situ to boost the activity of NK cells in the tumor. This article reviews the recent research progress in enhancing NK cell therapy based on biomaterial modification, to provide a reference for further researches on engineering NK cell therapy with biomaterials.
format Online
Article
Text
id pubmed-10409897
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher 《浙江大学学报》编辑部
record_format MEDLINE/PubMed
spelling pubmed-104098972023-08-10 生物材料增效NK细胞免疫疗法研究进展 Zhejiang Da Xue Xue Bao Yi Xue Ban Research Article NK cell immunotherapy is a promising antitumor therapeutic modality after the development of T cell immunotherapy. Structural modification of NK cells with biomaterials may provide a precise, efficient, and low-cost strategy to enhance NK cell immunotherapy. The biomaterial modification of NK cells can be divided into two strategies: surface engineering with biomaterials and intracellular modification. The surface engineering strategies include hydrophobic interaction of lipids, receptor-ligand interaction between membrane proteins, covalent binding to amino acid residues, click reaction and electrostatic interaction. The intracellular modification strategies are based on manipulation by nanotechnology using membranous materials from various sources of NK cells (such as exosome, vesicle and cytomembranes). Finally, the biomaterials-based strategies regulate the recruitment, recognition and cytotoxicity of NK cells in the solid tumor site in situ to boost the activity of NK cells in the tumor. This article reviews the recent research progress in enhancing NK cell therapy based on biomaterial modification, to provide a reference for further researches on engineering NK cell therapy with biomaterials. 《浙江大学学报》编辑部 2023-06-25 /pmc/articles/PMC10409897/ /pubmed/37476938 http://dx.doi.org/10.3724/zdxbyxb-2022-0728 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Research Article
生物材料增效NK细胞免疫疗法研究进展
title 生物材料增效NK细胞免疫疗法研究进展
title_full 生物材料增效NK细胞免疫疗法研究进展
title_fullStr 生物材料增效NK细胞免疫疗法研究进展
title_full_unstemmed 生物材料增效NK细胞免疫疗法研究进展
title_short 生物材料增效NK细胞免疫疗法研究进展
title_sort 生物材料增效nk细胞免疫疗法研究进展
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409897/
https://www.ncbi.nlm.nih.gov/pubmed/37476938
http://dx.doi.org/10.3724/zdxbyxb-2022-0728
work_keys_str_mv AT shēngwùcáiliàozēngxiàonkxìbāomiǎnyìliáofǎyánjiūjìnzhǎn
AT shēngwùcáiliàozēngxiàonkxìbāomiǎnyìliáofǎyánjiūjìnzhǎn